Study lead hopes findings will help in early identification of patients at increased risk of illness, in turn facilitating research and development of targeted treatments

One healthcare provider says it believes 10 died after refusing Regeneron's treatment; medication offered at no cost to patients since September, with priority to the unvaccinated

In letter to Health Ministry director, Ziv Medical Center points to promising results from Amor 18's clinical trial, where all patients who received drug went on to recover

World body okays arthritis drug baricitinib used with corticosteroids for severe patients, and synthetic antibody treatment for less serious cases

Paxlovid will be able to be taken at home to head off the worst effects of the virus; is first non-intravenous treatment for COVID-19 given the okay by the FDA

Virologist predicts shortage of GlaxoSmithKline's drug, the only one that remains effective, after Regeneron, Eli Lilly say their therapies appear less useful against new strain

Pharma giant also says full study results confirm medication reduces combined hospitalizations and deaths by about 89% among high-risk adults

FDA health advisers narrowly approve medicine by vote of 13-10; treatment set to become first drug Americans can take at home to treat infection

Drug company CEO Albert Bourla says it is 'moving as quickly as possible' to get the treatment into the hands of patients

Pharma giants Merck and Pfizer announce encouraging results for oral drugs that largely prevent serious forms of the illness, and hospitalization